Focus Partners Wealth
BSX icon

Focus Partners Wealth’s Boston Scientific BSX Stock Holding History

Focus Partners Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
383,366
-28,126
-7% -$1.53M 0.02% 559
2026
Q1 		$25.9M Sell
411,492
-171,753
-29% -$13.7M 0.03% 437
2025
Q4 		$55.6M Buy
583,245
+65,020
+13% +$6.37M 0.06% 267
2025
Q3 		$50.6M Buy
518,225
+194,947
+60% +$20.2M 0.08% 211
2025
Q2 		$34.7M Sell
323,278
-42,966
-12% -$4.35M 0.08% 244
2025
Q1 		$36.9M Sell
366,244
-13,072
-3% -$1.32M 0.09% 219
2024
Q4 		$33.9M Buy
379,316
+231,434
+156% +$20.4M 0.09% 222
2024
Q3 		$106M Sell
147,882
-459,230
-76% -$36.2M 0.34% 64
2024
Q2 		$47.1M Buy
607,112
+303,662
+100% +$22.2M 0.16% 142
2024
Q1 		$20.8M Buy
303,450
+293,014
+2,808% +$18.8M 0.17% 147
2023
Q4 		$603K Buy
+10,436
New +$557K 0.01% 544

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Focus Partners Wealth's BSX Position: Q2 2026 in Review

Focus Partners Wealth reduced its Boston Scientific (BSX) stake by 6.8% in Q2 2026, selling an estimated $1.53M and leaving 383,366 shares worth $16.4M. The position accounts for 0.02% of the portfolio, ranked #559.

Focus Partners Wealth first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $106M in Q3 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Focus Partners Wealth held 383,366 shares of Boston Scientific worth $16.4M as of Q2 2026.
  • Focus Partners Wealth sold 28,126 Boston Scientific shares in Q2 2026, an estimated $1.53M.
  • Boston Scientific made up 0.02% of Focus Partners Wealth's portfolio in Q2 2026, its #559 holding.
  • Focus Partners Wealth first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Boston Scientific position peaked at $106M in Q3 2024.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.